This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Senju Pharmaceutical Co., Ltd.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Yayoi Kishimoto: Innovator in Retinal Health
Introduction
Yayoi Kishimoto is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of retinal health through his innovative research and development. His work focuses on protecting retinal neurons, which is crucial for preventing vision loss in various eye diseases.
Latest Patents
Kishimoto holds a patent for a retinal ganglion cell death inhibitor. This invention relates to a suppressor that comprises a BMPR signal transduction inhibitor. The drug is designed to protect retinal neurons and is aimed at preventing or treating diseases involving retinal ganglion cell death, such as glaucoma, diabetic retinopathy, and retinal vascular occlusion. This patent highlights his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Kishimoto is associated with Senju Pharmaceutical Co., Ltd., where he continues to work on groundbreaking research. His dedication to innovation in the pharmaceutical industry has positioned him as a key figure in the development of treatments for retinal diseases.
Collaborations
Kishimoto collaborates with Chiho Yabuta, who is also involved in research related to retinal health. Their partnership exemplifies the importance of teamwork in scientific advancements.
Conclusion
Yayoi Kishimoto's contributions to retinal health through his innovative patent demonstrate his expertise and commitment to improving medical treatments. His work has the potential to significantly impact the lives of individuals suffering from retinal diseases.